S. Rusconi et al., Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure, ANTIVIR TH, 3(4), 1998, pp. 203-207
We examined the in vitro phenotypic and genotypic profiles of an extensivel
y passaged human immunodeficiency virus type 1 clinical isolate which has b
een selected for lamivudine resistance, with an M184V mutation in a zidovud
ine-resistant genetic background, and then cultured with zidovudine alone.
Our passaging strategy led to a decrease in lamivudine IC50 values, which w
ere comparable to those prior to lamivudine exposure, and the genotypic res
toration of the wild-type sequence at codon 184 of reverse transcriptase.